Archives

by in
Entry Author Date Location
Allen Institute Moving to South Lake Union as Growth Continues 11/02/12 Seattle
E. Donnall Thomas, Bone Marrow Transplant Pioneer at the Hutch, Dies at 92 10/21/12 Seattle
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
A Lonely Voice Asking Tough Questions on Cancer Cost-Effectiveness 07/30/12 National
Gates Foundation’s Jeff Raikes To Start Off Seattle Biotech Event 07/10/12 Seattle
A Computer Guy’s Dream, Immusoft, Turns Cells Into Drug Factories 07/05/12 Seattle
Fred Hutch Spinoff Blaze Bioscience Pulls in $5M For ‘Tumor Paint’ 06/08/12 Seattle
IDRI Makes Move From Old First Hill Digs to Shiny New SLU 06/01/12 Seattle
Hutch, UW Scientists Find Elusive Cancers With Adaptive Diagnostic 05/16/12 Seattle
Presage Looks to Help Millennium Pick Cancer Drug Winners Early 04/06/12 Seattle
PATH Names Former Tech Exec Steve Davis as New CEO 03/26/12 Seattle
Paul Allen’s Big Bet to ‘Uncover the Essence of What Makes Us Human’ 03/22/12 Seattle
Reinventing Biotech on April 3: Here’s the Agenda 03/08/12 Seattle
Xconomy Seattle’s Top 12 Life Sciences Stories of the Year 12/28/11 Seattle
The Year in Seattle Medical Devices, Diagnostics, Health IT 12/23/11 Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Some Notes on Immunex 11/29/11 Seattle
A Look Ahead for Washington State’s Life Sciences Cluster 11/16/11 Seattle
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors 10/18/11 Seattle
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Presage Adds $1.5M 08/10/11 Seattle
How Seattle Set Out to Create a Biotech Hub and Fostered a Global Health Nexus 08/08/11 Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Hutch, Sangamo Win $20M HIV Grant 07/11/11 Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News 06/09/11 Seattle
Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch 06/06/11 Seattle
Finding a Solution To Our Biotech Malaise Together 05/18/11 Seattle
Bill Gates’ Favorite Biofuel Company on the Docket for Thursday’s Alternative Fuels Event 05/16/11 Seattle
Page 2 of 7 « previous page · next page »